| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.042 | 0.4 |